
Frespas MF 80mg/250mg Tablet
Marketer
J Altius Healthcare
Salt Composition
Drotaverine (80mg) + Mefenamic Acid (250mg)
Overview Frespas MF 80mg/250mg Tablet
Abdominal pain is effectively treated with the combined medication, Frespas MF 80mg/250mg Tablet. This formulation alleviates abdominal pain, bloating, discomfort, and cramping by relaxing gastrointestinal muscles and inhibiting pain-inducing neurotransmitters. Frespas MF 80mg/250mg Tablets should be ingested with food, following your physician's prescribed dosage and regimen. Dosage is tailored to individual needs and response. Continue treatment as directed; premature discontinuation may lead to symptom recurrence and condition exacerbation. Inform your healthcare provider of all concurrent medications, as interactions are possible. Common, usually transient, side effects include diarrhea, nausea, vomiting, stomach pain, dry mouth, anorexia, thirst, and heartburn. Report any concerning side effects immediately. Dizziness and drowsiness are possible; refrain from driving or activities requiring alertness until effects are known. Alcohol consumption should be avoided due to potential dizziness exacerbation. Prior to commencing treatment, disclose pregnancy, pregnancy plans, breastfeeding, and any kidney or liver conditions to ensure appropriate dosage.
Primary Ingredients of Frespas MF 80mg/250mg Tablet
The provided text is "undefined," offering no content to rephrase.
Uses of Frespas MF 80mg/250mg Tablet
Managing abdominal discomfort
Major Benefits of Frespas MF 80mg/250mg Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Frespas MF 80mg/250mg Tablet whole; avoid crushing, chewing, or breaking it. Administer this medicine with food.
Common Side effects of Frespas MF 80mg/250mg Tablet:
- Nausea
- Vomiting
- Diarrhea
- Dryness in mouth
- Heartburn
- Vertigo
- Insomnia (difficulty in sleeping)
- Hypotension (low blood pressure)
- Fast heart rate
- Sweating
- Constipation
- Increased liver enzymes
- Increased white blood cell count (eosinophils)
- Decreased white blood cell count (lymphocytes)
- Low blood platelets
- Purpura
- Agranulocytosis (deficiency of granulocytes in the blood)
- Breathlessness
- Ringing in ear
- Abdominal pain
- Flatulence
- Indigestion
- Stomach inflammation
- Confusion
- Depression
How to use Frespas MF 80mg/250mg Tablet:
Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. The Frespas MF 80mg/250mg Tablet should be administered with a meal.
How Frespas MF 80mg/250mg Tablet works:
Each Frespas MF 80mg/250mg tablet combines drotaverine and mefenamic acid to alleviate abdominal cramping and pain. Drotaverine, an antispasmodic, targets abdominal smooth muscle spasms, easing contractions. Mefenamic acid, a nonsteroidal anti-inflammatory drug (NSAID), reduces pain and inflammation by inhibiting the production of inflammatory mediators.
SAFETY ADVICE
AlcoholUNSAFE
Alcohol consumption alongside Frespas MF 80mg/250mg Tablets is inadvisable.
PregnancyCONSULT YOUR DOCTOR
Using Frespas MF 80mg/250mg tablets during pregnancy may pose risks. While human data is scarce, animal studies indicate potential harm to the unborn child. A physician will assess the potential advantages against any risks prior to prescribing this medication. Seek medical advice before use.
Breast feedingCONSULT YOUR DOCTOR
Data on the safety of Frespas MF 80mg/250mg Tablet while breastfeeding is lacking. Seek medical advice from your physician.
DrivingUNSAFE
Driving ability may be impaired by Frespas MF 80mg/250mg Tablets, a potential side effect of the medication due to the risk of dizziness.
KidneyCAUTION
Patients with kidney impairment should use Frespas MF 80mg/250mg tablets cautiously, potentially requiring dosage modification. Consult a physician for guidance. Frespas MF 80mg/250mg tablets are contraindicated in individuals with severe kidney disease.
LiverCAUTION
Patients with hepatic impairment should exercise caution when using Frespas MF 80mg/250mg tablets. Dosage modification may be necessary; physician consultation is recommended.
What if you forget to take Frespas MF 80mg/250mg Tablet :
Should you forget a dose of Frespas MF 80mg/250mg Tablet, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Frespas MF 80mg/250mg Tablet
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Gastrointestinal system |
